The second-most abundant flavonoid in this sub-fraction was tentatively identified as liquiritigenin, which has been shown to decrease viability in breast cancer MDAMB-231 and BT549 cell lines by increasing apoptosis and enhancing caspase-3 activity in these cells [94]. The gene discussed is CASP3; the disease is breast carcinoma.